Literature DB >> 8824333

Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra.

F C Zhou1, Y H Chiang, Y Wang.   

Abstract

The physical repair and restoration of a completely damaged pathway in the brain has not been achieved previously. In a previous study, using excitatory amino acid bridging and fetal neural transplantation, we demonstrated that a bridged mesencephalic transplant in the substantia nigra generated an artificial nerve pathway that reinnervated the striatum of 6-hydroxydopamine (6-OHDA)-lesioned rats. In the current study, we report that a bridged mesencephalic transplant can anatomically, neurochemically, and functionally reinstate the 6-OHDA-eradicated nigro-striatal pathway. An excitatory amino acid, kainic acid, laid down in a track during the transplant generated a trophic environment that effectively guided the robust growth of transplanted neuronal fibers in a bundle to innervate the distal striatum. Growth occurred at the remarkable speed of approximately 200 microm/d. Two separate and distinct types of dopamine (DA) innervation from the transplant have been achieved for the first time: (1) DA innervation of the striatum, and (2) DA innervation of the pars reticularis of the substantia nigra. In addition, neuronal tracing revealed that reciprocal connections were achieved. The grafted DA neurons in the SNr innervated the host's striatum, whereas the host's striatal neurons, in turn, innervated the graft within 3-8 weeks. Electrochemical volt- ammetry recording revealed the restoration of DA release and clearance in a broad striatal area associated with the DA reinnervation. Furthermore, the amphetamine-induced rotation was attenuated, which indicates that the artificial pathways were motor functional. This study provides additional evidences that our bridged transplantation technique is a potential means for the repair of a completely damaged neuronal pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824333      PMCID: PMC6579253     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

1.  Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments.

Authors:  A M Graybiel; R Moratalla
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Afferent and efferent connections of striatal grafts implanted into the ibotenic acid lesioned neostriatum in adult rats.

Authors:  M Pritzel; O Isacson; P Brundin; L Wiklund; A Björklund
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

3.  Monitoring release of neurotrophic activity in the brains of awake rats.

Authors:  C Humpel; E Lindqvist; S Söderström; A Kylberg; T Ebendal; L Olson
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

4.  Neural transplantation: a special issue.

Authors:  W J Freed
Journal:  Exp Neurol       Date:  1993-07       Impact factor: 5.330

5.  Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size.

Authors:  E Castañeda; I Q Whishaw; T E Robinson
Journal:  J Neurosci       Date:  1990-06       Impact factor: 6.167

6.  Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.

Authors:  J H Kordower; T B Freeman; B J Snow; F J Vingerhoets; E J Mufson; P R Sanberg; R A Hauser; D A Smith; G M Nauert; D P Perl
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

7.  Rapid serotonergic fiber sprouting in response to ibotenic acid lesion in the striatum and hippocampus.

Authors:  F C Zhou; E C Azmitia; S Bledsoe
Journal:  Brain Res Dev Brain Res       Date:  1995-01-14

Review 8.  Clinical application of cell transplantation and neurotrophic factors in CNS disorders.

Authors:  O Lindvall; P Odin
Journal:  Curr Opin Neurobiol       Date:  1994-10       Impact factor: 6.627

9.  Restoration of dopamine overflow and clearance from the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal mesencephalic grafts.

Authors:  Y Wang; S D Wang; S Z Lin; J C Liu
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

10.  Transection of corticostriatal afferents abolishes the hyperexpression of Fos and counteracts the development of rotational overcompensation induced by intrastriatal dopamine-rich grafts when challenged with amphetamine.

Authors:  M A Cenci; A Björklund
Journal:  Brain Res       Date:  1994-11-28       Impact factor: 3.252

View more
  10 in total

1.  Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway.

Authors:  Seong-Jin Yu; Mikko Airavaara; Hui Shen; Jenny Chou; Brandon K Harvey; Yun Wang
Journal:  Psychopharmacology (Berl)       Date:  2011-12-13       Impact factor: 4.530

2.  Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?

Authors:  Kai Loewenbrück; Alexander Storch
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

3.  A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra.

Authors:  M J Wilby; S R Sinclair; E M Muir; R Zietlow; K H Adcock; P Horellou; J H Rogers; S B Dunnett; J W Fawcett
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

4.  Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke.

Authors:  Brandon K Harvey; Mikko Airavaara; Jason Hinzman; Emily M Wires; Matthew J Chiocco; Douglas B Howard; Hui Shen; Greg Gerhardt; Barry J Hoffer; Yun Wang
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

5.  Development of a novel radioligand for imaging 18-kD translocator protein (TSPO) in a rat model of Parkinson's disease.

Authors:  Chun-Yi Wu; Yang-Yi Chen; Jia-Jia Lin; Jui-Ping Li; Jen-Kun Chen; Te-Chun Hsieh; Chia-Hung Kao
Journal:  BMC Med Imaging       Date:  2019-09-18       Impact factor: 1.930

6.  Enhanced prostacyclin synthesis by adenoviral gene transfer reduced glial activation and ameliorated dopaminergic dysfunction in hemiparkinsonian rats.

Authors:  May-Jywan Tsai; Ching-Feng Weng; Nien-Chu Yu; Dann-Ying Liou; Fu-San Kuo; Ming-Chao Huang; Wen-Cheng Huang; Kabik Tam; Song-Kun Shyue; Henrich Cheng
Journal:  Oxid Med Cell Longev       Date:  2013-04-03       Impact factor: 6.543

Review 7.  Restoring lost nigrostriatal fibers in Parkinson's disease based on clinically-inspired design criteria.

Authors:  Wisberty J Gordián-Vélez; Dimple Chouhan; Rodrigo A España; H Isaac Chen; Jason A Burdick; John E Duda; D Kacy Cullen
Journal:  Brain Res Bull       Date:  2021-07-28       Impact factor: 3.715

8.  Development of a stereotaxic device for low impact implantation of neural constructs or pieces of neural tissues into the mammalian brain.

Authors:  Andrzej Jozwiak; Yiwen Liu; Ying Yang; Monte A Gates
Journal:  Biomed Res Int       Date:  2014-01-23       Impact factor: 3.411

Review 9.  Reducing excitoxicity with glutamate transporter-1 to treat stroke.

Authors:  Yun Wang; Brandon K Harvey
Journal:  Brain Circ       Date:  2016-10-18

Review 10.  Enhanced survival of human-induced pluripotent stem cell transplant in parkinsonian rat brain by locally applied cyclosporine.

Authors:  Michael Sheyner; Seong-Jin Yu; Yun Wang
Journal:  Brain Circ       Date:  2019-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.